<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03426696</url>
  </required_header>
  <id_info>
    <org_study_id>201701</org_study_id>
    <nct_id>NCT03426696</nct_id>
  </id_info>
  <brief_title>Psychological Status and Related Factors of Thyroid Related Eye Disease</brief_title>
  <official_title>Psychological Status and Related Factors of Thyroid Related Eye Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Huijing Ye</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sun Yat-sen University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the psychological status of Thyroid Related Eye
      Disease.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to evaluate the psychological status of patients of Thyroid
      Related Eye Disease over 16 years old, and to analyze the related factors of them.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 1, 2017</start_date>
  <completion_date type="Anticipated">December 1, 2018</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Quality of life questionnaire of patients of Thyroid Related Eye Disease</measure>
    <time_frame>immediately</time_frame>
    <description>Graves ́ ophthalmopathy quality of life questionnaire (GO-QoL) , The GO-QoL contains 8 questions on visual functioning and 8 questions on appearance; answers on each subscale are transformed to scores ranging from 0 (worst) to 100 (best).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Symptom checklist 90(SLC-90)</measure>
    <time_frame>immediately</time_frame>
    <description>It consists of 90 items yielding nine scores along primary symptom dimensions and three scores among global distress indices. The primary symptom dimensions that are assessed are somatization, obsessive-compulsive, interpersonal sensitivity, depression, anxiety, hostility, phobic anxiety, paranoid ideation, psychoticism, and a category of &quot;additional items&quot; which helps clinicians assess other aspect of the clients symptoms. Positive standard includes: total score 160 points or more, or positive items &gt; 43 points, or any item &gt; 2 points.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hamilton anxiety scale(HAMA)</measure>
    <time_frame>immediately</time_frame>
    <description>This scale includes 14 items. All projects rated as: asymptomatic, light, medium, heavy, or very heavy. If the total score more than 29 points, there could be severe anxiety; more than 21 points, affirmation have obvious anxiety; more than 14 points, there must be some anxious; more than 7 points might be anxious; if less than 6 points, patients without anxiety symptoms.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Somatic self-rating scale(SSS)</measure>
    <time_frame>immediately</time_frame>
    <description>Somatic self-rating scale can let the doctor fully understand patients' mood and somatization symptoms. If the selected items scores more than 30 points, the patient may need to clinic treatment.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hamilton depression scale(HAMD)</measure>
    <time_frame>immediately</time_frame>
    <description>It is the most common depression clinical application scale. Lower score presents lighter condition, and if the illness is heavier, the higher is the score. There is no depression symptoms for score less than eight points.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Young manic rating scale(YMRS)</measure>
    <time_frame>immediately</time_frame>
    <description>The Young Mania Rating Scale (YMRS) is a diagnostic questionnaire commonly used to evaluate manic symptoms in patients with bipolar 1 disorder and to assess treatment efficacy in clinical trials. This rating scale comprises eleven items (elevated mood, increased motor activity - energy, sexual interest, sleep, irritability, speech - rate and amount, language-thought disorder, content, disruptive-aggressive behavior, appearance, and insight). The total YMRS score is calculated as the summation of each of the eleven individual item scores.Lower score presents lighter condition, and if the illness is heavier, the higher is the score.There is no manic symptoms for score less than five points.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Thyroid Related Eye Disease</condition>
  <arm_group>
    <arm_group_label>Thyroid Related Eye Disease</arm_group_label>
    <description>Survey about the psychological condition would done with the patients of Thyroid Related Eye Disease</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>psychological condition</intervention_name>
    <description>Graves ́ ophthalmopathy quality of life questionnaire, Symptom checklist 90(SLC-90), Hamilton anxiety scale(HAMA), Somatic self-rating scale(SSS), MATRICS Consensus Cognitive Battery (MCCB), Hamilton depression scale(HAMD)</description>
    <arm_group_label>Thyroid Related Eye Disease</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients in Sun Yat-sen University that diagnosed as Thyroid Related Eye Disease
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  over 16 years old

          -  diagnosed as Thyroid Related Eye Disease

        Exclusion Criteria:

          -  any uncontrolled clinical problems
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Huijing Ye, Master</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sun Yat-sen University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Huijing Ye, Master</last_name>
    <phone>+00862087331539</phone>
    <email>yehuijing@qq.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Huasheng Yang, Doctor</last_name>
    <phone>+00862087331539</phone>
    <email>yanghs64@126.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Sun Yat-sen University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Huijing Ye, Master</last_name>
      <phone>00862087331539</phone>
      <email>yehuijing@qq.com</email>
    </contact>
    <contact_backup>
      <last_name>Huasheng Yang, Doctor</last_name>
      <phone>00862087331539</phone>
      <email>yanghs64@126.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 1, 2018</study_first_submitted>
  <study_first_submitted_qc>February 7, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">February 8, 2018</study_first_posted>
  <last_update_submitted>February 7, 2018</last_update_submitted>
  <last_update_submitted_qc>February 7, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 8, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Sun Yat-sen University</investigator_affiliation>
    <investigator_full_name>Huijing Ye</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>psychological status</keyword>
  <keyword>Related Factors</keyword>
  <keyword>Thyroid Related Eye Disease</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thyroid Diseases</mesh_term>
    <mesh_term>Eye Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

